Skip to main content

Loading market data...

CNC

Centene Corporation

NYSE • United states

$70.81

+$2.18

(+3.18%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:03 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Centene Corporation (CNC)

Unavailable

Quotes may be delayed

$34.98B

Market Cap

3,391,163

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Centene Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 7700 FORSYTH BLVD., ST LOUIS, MO
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

8 Oct 2026

Centene Corporation reported Another company event

Centene Corporation filed an 8-K covering another company event.

16 Sep 2026

Centene Corporation reported Regulation FD disclosure

Centene Corporation filed an 8-K covering Regulation FD disclosure.

17 Aug 2026

Centene Corporation reported A director or senior management change or compensation event

Centene Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

29 Jul 2026

Centene Corporation reported Another company event

Centene Corporation filed an 8-K covering another company event.

28 Jul 2026

Centene Corporation reported Operating or financial results

Centene Corporation filed an 8-K covering operating or financial results, a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$24.15B

Total assets (USD)$83.01B

Total liabilities (USD)$60.36B

Shareholders' equity (USD)$22.56B

Long-term debt (USD)$16.03B

Debt due within a year (USD)$75.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$44.38B	$1.20B	$1.09B	$2.19	10-Q · 28 Jul 2026
Q1 2026	$44.66B	$1.86B	$1.54B	$3.11	10-Q · 28 Apr 2026
Q4 2025	$44.73B	−$1.75B	−$1.10B	Unavailable	10-K · 17 Feb 2026
Q3 2025	$44.90B	−$6.95B	−$6.63B	−$13.50	10-Q · 29 Oct 2025
Q2 2025	$42.47B	−$458.00M	−$253.00M	−$0.51	10-Q · 25 Jul 2025
Q1 2025	$42.49B	$1.53B	$1.31B	$2.63	10-Q · 25 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $72.92

3.0% upside potential

📈

Strong Buy

Unavailable

👍

Buy

6

⏸️

Hold

8

📉

Sell

0

14 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 22:49 UTC Targets range 65.00–80.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

15

Oct 2026

Carson Michael A

Group President, Medicare&Spec

Tax withholding

$70.16 per share

7,130 shares

30

Sep 2026

Tyler Lauren M

Director

Grant or award

Unavailable per share

482 shares

30

Sep 2026

TANJI KENNETH

Director

Grant or award

Unavailable per share

603 shares

30

Sep 2026

Samuels Theodore R. II

Director

Grant or award

Unavailable per share

583 shares

30

Sep 2026

EPPINGER FREDERICK H

Director

Grant or award

Unavailable per share

864 shares

30

Sep 2026

COUGHLIN CHRISTOPHER J

Director

Grant or award

Unavailable per share

583 shares

15

Sep 2026

PIENKOS THEODORE J

Corporate Controller & CAO

Tax withholding

$69.41 per share

1,092 shares

26

Aug 2026

KOSTER CHRISTOPHER

Secretary & General Counsel

Open-market sale

$66.90 per share

56,500 shares

Top Shareholders

Vanguard Group Inc

56,978,753 shares

0.335% change

12/31/2025

Blackrock, Inc.

41,446,046 shares

4.077% change

6/30/2026

Vanguard Capital Management Llc

31,478,140 shares

0.781% change

6/30/2026

Aqr Capital Management Llc

28,678,701 shares

-14.682% change

6/30/2026

Vanguard Portfolio Management Llc

22,352,704 shares

3.343% change

6/30/2026

State Street Corp

21,965,370 shares

1.475% change

6/30/2026

Geode Capital Management, Llc

13,309,729 shares

2.481% change

6/30/2026

Wellington Management Group Llp

13,301,215 shares

422.99% change

6/30/2026

Ameriprise Financial Inc

12,419,397 shares

22.622% change

6/30/2026

Invesco Ltd.

11,179,844 shares

5.31% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 22:49 UTC· 1 day ago

Research coverage and investment tools

Centene Corporation (CNC) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical Specialities). Its last price was US$70.81 on 20 Oct 2026. That is 99% of the way from its 52-week low of US$31.63 to its 52-week high of US$71.21. Its market capitalisation was US$34.98 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$44.38B	$1.20B	$1.09B	$2.19	10.4%	2.7%	$3.42B	10-Q · 28 Jul 2026 (opens in a new tab)
Q1 2026	$44.66B	$1.86B	$1.54B	$3.11	12.7%	4.2%	$4.17B	10-Q · 28 Apr 2026 (opens in a new tab)
Q4 2025	$44.73B	−$1.75B	−$1.10B	Unavailable	5.7%	-3.9%	$224.00M	10-K · 17 Feb 2026 (opens in a new tab)
Q3 2025	$44.90B	−$6.95B	−$6.63B	−$13.50	7.5%	-15.5%	$1.15B	10-Q · 29 Oct 2025 (opens in a new tab)
Q2 2025	$42.47B	−$458.00M	−$253.00M	−$0.51	7.1%	-1.1%	$1.58B	10-Q · 25 Jul 2025 (opens in a new tab)
Q1 2025	$42.49B	$1.53B	$1.31B	$2.63	12.4%	3.6%	$1.38B	10-Q · 25 Apr 2025 (opens in a new tab)

Cash and equivalents: $24.15B
Total assets: $83.01B
Total liabilities: $60.36B
Shareholders' equity: $22.56B
Long-term debt: $16.03B
Debt due within a year: $75.00M

8-K · 8 Oct 2026

Centene Corporation reported Another company event (opens in a new tab)

Centene Corporation filed an 8-K covering another company event.
8-K · 16 Sep 2026

Centene Corporation reported Regulation FD disclosure (opens in a new tab)

Centene Corporation filed an 8-K covering Regulation FD disclosure.
8-K · 17 Aug 2026 · Management change

Centene Corporation reported A director or senior management change or compensation event (opens in a new tab)

Centene Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 29 Jul 2026

Centene Corporation reported Another company event (opens in a new tab)

Centene Corporation filed an 8-K covering another company event.
8-K · 28 Jul 2026

Centene Corporation reported Operating or financial results (opens in a new tab)

Centene Corporation filed an 8-K covering operating or financial results, a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Carson Michael A Group President, Medicare&Spec	15 Oct 2026	Tax withholding (F)	−7,130	$70.16	Form 4 (opens in a new tab)
Tyler Lauren M Director	30 Sep 2026	Grant or award (A)	+482	—	Form 4 (opens in a new tab)
TANJI KENNETH Director	30 Sep 2026	Grant or award (A)	+603	—	Form 4 (opens in a new tab)
Samuels Theodore R. II Director	30 Sep 2026	Grant or award (A)	+583	—	Form 4 (opens in a new tab)
EPPINGER FREDERICK H Director	30 Sep 2026	Grant or award (A)	+864	—	Form 4 (opens in a new tab)
COUGHLIN CHRISTOPHER J Director	30 Sep 2026	Grant or award (A)	+583	—	Form 4 (opens in a new tab)
PIENKOS THEODORE J Corporate Controller & CAO	15 Sep 2026	Tax withholding (F)	−1,092	$69.41	Form 4 (opens in a new tab)
KOSTER CHRISTOPHER Secretary & General Counsel	26 Aug 2026	Open-market sale (S)	−56,500	$66.90	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	56,978,753	0.335%
Blackrock, Inc.	6/30/2026	41,446,046	4.077%
Vanguard Capital Management Llc	6/30/2026	31,478,140	0.781%
Aqr Capital Management Llc	6/30/2026	28,678,701	-14.682%
Vanguard Portfolio Management Llc	6/30/2026	22,352,704	3.343%
State Street Corp	6/30/2026	21,965,370	1.475%
Geode Capital Management, Llc	6/30/2026	13,309,729	2.481%
Wellington Management Group Llp	6/30/2026	13,301,215	422.99%
Ameriprise Financial Inc	6/30/2026	12,419,397	22.622%
Invesco Ltd.	6/30/2026	11,179,844	5.31%

Previous close: 68.63 USD
Day range: 68.90 – 70.97 USD
52-week range: 31.63 – 71.21 USD
Volume: 3,391,163
Market cap: $34.98B
Average volume: 3,680,525
EPS (FY 2025, diluted): −13.53 USD
Shares outstanding: 494.00M
Beta (5Y monthly): 1.10

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:03 UTC· 1 day ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:07 UTC· 31 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for CNC yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.